Category: Press Release

bonyf Announces Plans for Dual Listing on Nasdaq and Euronext Paris with a Five-Step Strategy
Post

bonyf Announces Plans for Dual Listing on Nasdaq and Euronext Paris with a Five-Step Strategy

Knokke-Heist (Belgium), 18 February 2025, 6:00 a.m.; bonyf NV (Ticker: MLBON) today announced its strategic plan to pursue a dual listing on the Nasdaq Stock Market while maintaining its current listing on Euronext Paris. This initiative is aimed at expanding the company’s global footprint, diversifying its investor base, and accelerating growth opportunities in the U.S. and international markets.

bonyf and Honest Pharma are pleased to announce a Strategic Alliance to bring revolutionary oral care products to the US market
Post

bonyf and Honest Pharma are pleased to announce a Strategic Alliance to bring revolutionary oral care products to the US market

Knokke-Heist (Belgium), 10 December 2024, 6:00 a.m.; bonyf NV (Ticker: MLBON) is committed to advancing oral health solutions that enhance patient well-being. Today, the company is pleased to announce a significant milestone: the successful certification of NitrAdine® Disinfecting Tablets under the stringent European Union’s Medical Device Regulation (MDR), marking a new chapter in its pursuit of excellence.

bonyf Achieves MDR Certification, Strengthening Commitment to Excellence in Oral Care Solutions
Post

bonyf Achieves MDR Certification, Strengthening Commitment to Excellence in Oral Care Solutions

Knokke-Heist (Belgium), 9 December 2024, 6:00 a.m.; bonyf NV (Ticker: MLBON) is committed to advancing oral health solutions that enhance patient well-being. Today, the company is pleased to announce a significant milestone: the successful certification of NitrAdine® Disinfecting Tablets under the stringent European Union’s Medical Device Regulation (MDR), marking a new chapter in its pursuit of excellence.

bonyf expands its global formulation footprint through a strategic alliance with Group Pharmaceuticals Ltd, signing a license agreement to produce NitrAdine® for India
Post

bonyf expands its global formulation footprint through a strategic alliance with Group Pharmaceuticals Ltd, signing a license agreement to produce NitrAdine® for India

Knokke-Heist (Belgium), 28 November 2024, 6:00 a.m.; bonyf NV (Ticker: MLBON) and Group pharmaceuticals Ltd are pleased to announce a strategic alliance with a license agreement on the NitrAdine® formulation to manufacture and distribute in India the bonyf products NitrAdine® denture cleansing & disinfecting tablets.

Annual Results 2023
Post

Annual Results 2023

Ghent (Belgium), 19 September 2024, 6:00 a.m.; bonyf NV (Ticker: MLBON) presents its 2023 financial statements, approved by its Board of Directors and audited by its Statutory Auditors.